Bookmark and Share
sodium arsenite (CID 443495) - Compound BioActivity Data
.
BioActivity Outcomes:
Inactive(4)
 
 
Unspecified(672)
 
 
Top Targets:
7tm 4(31)
 
 
p450(8)
 
 
NR LBD ER(2)
 
 
Tryp SPc(2)
 
 
NOS oxygenase..(2)
 
 
BioAssay Types:
Confirmatory(116)
 
 
BioActivity Types:
IC50(116)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 676    Data Row: 676   Total Pages: 34   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID136944588]
IC50 DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine) [AID625158, Type: confirmatory]
View
2
[SID136944588]
DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu) [AID625164, Type: other]
View
3
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S010924 [AID1034136, Type: other]
View
4
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S010924 [AID1034137, Type: other]
View
5
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S010924 [AID1034138, Type: other]
View
6
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S010924 [AID1034139, Type: other]
View
7
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S010924 [AID1034130, Type: other]
View
8
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S010924 [AID1034131, Type: other]
View
9
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S010924 [AID1034132, Type: other]
View
10
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S010924 [AID1034133, Type: other]
View
11
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S010924 [AID1034134, Type: other]
View
12
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S010924 [AID1034135, Type: other]
View
13
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S010924 [AID1034124, Type: other]
View
14
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S010924 [AID1034125, Type: other]
View
15
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S010924 [AID1034126, Type: other]
View
16
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S010924 [AID1034127, Type: other]
View
17
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S010924 [AID1034128, Type: other]
View
18
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S010924 [AID1034129, Type: other]
View
19
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S010924 [AID1034118, Type: other]
View
20
[SID136944588]
DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: High; Vehicle: 100 % saline; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S010924 [AID1034119, Type: other]
View